Anticoagulation management before and after heart surgery

The natural ability of body to form blood clots is vital for controlling bleeding and healing but can pose significant risks around the time of any surgery. Patients undergoing heart surgery are especially at increased risk of developing clots, particularly those with conditions such as atrial fibrillation, artificial heart valves or previous thromboembolic events (for e.g. DVT, or pulmonary embolism) and therefore need adequate anticoagulation (thinning of blood) Conversely, excessive anticoagulation can increase the risk of major bleeding during or after the operation.

Anticoagulation management involves striking the right balance - minimising clotting risks but at the same time preventing unnecessary bleeding.

Pre-operative anticoagulation considerations

Before heart surgery, patients who are already taking anticoagulants such as warfarin, apixaban, rivaroxaban or dabigatran will usually need to stop these medications in advance. The exact timing will depend on:

The type of anticoagulant used
The patient’s kidney function
Nature of surgery and the bleeding risk associated with the planned surgery
The individual’s clotting risk from various medical conditions

In some cases, bridging therapy with another form of anticoagulant, something with shorter duration of action such as heparin or low molecular weight heparin (LMWH) may be necessary. This helps to reduce clotting risk while allowing the medications as above to be safely paused before surgery.

A pre-operative assessment by a multidisciplinary team helps determine the most appropriate anticoagulation strategy and ensures the surgery can proceed with minimal risk..

Post-operative anticoagulation management

After heart surgery, anticoagulation must be carefully restarted. The timing and type of therapy depend on the procedure performed and the patient’s individual risk profile.

For example:

After valve replacement, warfarin therapy is often required to prevent valve-related clots. If the valve is a mechanical valve, this is long-term i.e. lifelong and with Warfarin. long-term.
Following CABG surgery, anticoagulants may sometimes be used short-term, with most patients requiring antiplatelet therapy such as aspirin or clopidogrel.

Close monitoring is required to adjust dosing, particularly for warfarin, where regular blood tests (INR monitoring) ensure levels remain in the therapeutic range (i.e. effective blood thinning with least risk of bleeding complications).

Patients may need to remain in hospital for such management, to ensure there is stability and it is deemed safe to discharge with reliability that further management can be undertaken safely as an outpatient.

Patient education and follow-up

Effective anticoagulation management extends beyond hospital care. Patients must be informed about:

How and when to take their medication
Signs of bleeding or clotting to watch for
The importance of regular monitoring (e.g., INR checks)
The need to inform healthcare providers of their anticoagulation status before procedures or dental work

Warfarin levels (INR levels) are sensitive and can change due to interactions with food and medications and patient should be cautious about this.

Regular follow-up with a cardiologist, physician or anticoagulation clinic ensures long-term safety and effectiveness of anticoagulation treatment.

Why tailored anticoagulation plans matter

Every patient’s needs are different. A personalised approach to anticoagulation before and after heart surgery reduces complications and supports recovery. With expert oversight and good communication, patients can safely navigate the complexities of anticoagulation therapy as part of their surgical journey.

If you're interested in arranging a consultation with Mr Srivastava, Cardiothoracic surgeon in Oxford, you can do so via his Top Doctors profile.